Estados Unidos · Prensa financiera · Investor's Business Daily

Nurix, Sanofi Diverge — And One Breaks Out — On A Shocking Eczema Development

Publicado por Investor's Business Daily · Estados Unidos hace 2 h

Shares of Nurix Therapeutics crashed Wednesday after Sanofi unexpectedly scrapped an experimental eczema drug that two were codeveloping. The post Nurix, Sanofi Diverge — And One…

Leer el artículo completo en Investor's Business Daily Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.investors.com)

Nurix, Sanofi Diverge — And One Breaks Out — On A Shocking Eczema Development

También te puede interesar

U.S. Crude Oil Stockpiles Post Fifth Straight Weekly Drop

Amdocs Stock Has Its Worst Day in 24 Years as T-Mobile Business Is at Risk

Nurix, Sanofi Diverge — And One Breaks Out — On A Shocking Eczema Development

Compartir

También te puede interesar

U.S. Crude Oil Stockpiles Post Fifth Straight Weekly Drop

Amdocs Stock Has Its Worst Day in 24 Years as T-Mobile Business Is at Risk